Taiwania Capital, founded in 2017 and based in Taipei, Taiwan, is a venture capital firm focused on fostering economic growth in Taiwan through strategic partnerships with global companies. The firm manages multiple funds, including those that target early-stage investments in various sectors such as enterprise software, artificial intelligence, autonomous systems, and information technology. Additionally, Taiwania Capital has dedicated funds for specific regions, investing in markets like the United States, Japan, Israel, and Eastern and Northern Europe. Its investment strategy encompasses a wide range of industries, including healthcare, biotechnology, and consumer products, aiming to support innovation and development in these fields.
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.